These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31661825)

  • 21. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan.
    Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV
    Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.
    Aubry A; Sougakoff W; Bodzongo P; Delcroix G; Armand S; Millot G; Jarlier V; Courcol R; Lemaître N
    PLoS One; 2014; 9(4):e95083. PubMed ID: 24743770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Quantamatrix Multiplexed Assay Platform and GenoType MTBDR Assay Using Smear-Positive Sputum Specimens From Patients With Multidrug- Resistant/Extensively Drug-Resistant Tuberculosis in South Korea.
    Kim S; Kim Y; Chang Y; Hirgo WK; Chang CL; Shim TS; Uh Y; Lee H
    Front Microbiol; 2019; 10():1075. PubMed ID: 31139175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
    Ei PW; Aung WW; Nyunt WW; Swe TL; Htwe MM; Win SM; Aung ST; Chang CL; Lee HY; Lee JS
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):47-53. PubMed ID: 29297425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Genetic Mutations in Multi-Drug-Resistant Isolates of Mycobacterium tuberculosis Bacilli Conferring Resistance to a Second-Line Anti-tuberculosis Drug.
    Sharma RK; Kumari U; Kumari N; Kumar R
    Cureus; 2023 Jun; 15(6):e40442. PubMed ID: 37456413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study.
    Tagliani E; Cabibbe AM; Miotto P; Borroni E; Toro JC; Mansjö M; Hoffner S; Hillemann D; Zalutskaya A; Skrahina A; Cirillo DM
    J Clin Microbiol; 2015 Sep; 53(9):2961-9. PubMed ID: 26179309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of
    Elegail A; Ibrahim Mohamed NY; Mohamed Nour EO; Hoffner S; Haile M
    Int J Mycobacteriol; 2018; 7(3):236-241. PubMed ID: 30198502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.
    Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE
    Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
    Singhal P; Dixit P; Singh P; Jaiswal I; Singh M; Jain A
    Indian J Med Res; 2016 Mar; 143(3):341-7. PubMed ID: 27241648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Investigation of extensive drug resistance in multidrug resistance tuberculosis isolates].
    Bektöre B; Haznedaroğlu T; Baylan O; Ozyurt M; Ozkütük N; Satana D; Cavuşoğlu C; Seber E
    Mikrobiyol Bul; 2013 Jan; 47(1):59-70. PubMed ID: 23390903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico.
    Juarez-Eusebio DM; Munro-Rojas D; Muñiz-Salazar R; Laniado-Laborín R; Martinez-Guarneros JA; Flores-López CA; Zenteno-Cuevas R
    Infect Genet Evol; 2017 Nov; 55():384-391. PubMed ID: 27637930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predominance of Beijing genotype in extensively drug resistant Mycobacterium tuberculosis isolates from a tertiary care hospital in New Delhi, India.
    Arora J; Bhalla M; Sidiq Z; Lal P; Behera D; Rastogi N; Myneedu VP
    Int J Mycobacteriol; 2013 Jun; 2(2):109-13. PubMed ID: 26785898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extensively drug-resistant tuberculosis (XDR-TB) in Morocco.
    Ennassiri W; Jaouhari S; Cherki W; Charof R; Filali-Maltouf A; Lahlou O
    J Glob Antimicrob Resist; 2017 Dec; 11():75-80. PubMed ID: 28743645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.
    Nguyen HB; Nguyen NV; Tran HT; Nguyen HV; Bui QT
    Western Pac Surveill Response J; 2016; 7(2):35-40. PubMed ID: 27508089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China.
    Gao Y; Zhang Z; Deng J; Mansjö M; Ning Z; Li Y; Li X; Hu Y; Hoffner S; Xu B
    J Infect; 2018 Oct; 77(4):328-334. PubMed ID: 29969597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of gyrA and gyrB mutations associated with fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Morocco.
    Chaoui I; Oudghiri A; El Mzibri M
    J Glob Antimicrob Resist; 2018 Mar; 12():171-174. PubMed ID: 29033301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
    Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
    Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.